SCHEMBL2954471

SCHEMBL2954471

O=S(=O)(c1cnc(Cl)c2ccccc12)N1CCC(NCC2CC2)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.39
NPY5R Q15761 3/20 0.39
PDCD1 Q15116 1/20 0.38
CD274 Q9NZQ7 1/20 0.38
HTR7 P34969 5/20 0.37
HTR6 P50406 5/20 0.37
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
POLB P06746 1/20 0.36
HTR1A P08908 3/20 0.36
DRD2 P14416 3/20 0.36
HTR2A P28223 3/20 0.36
ALDH1A1 P00352 2/20 0.36
ACLY P53396 1/20 0.36
LMNA P02545 1/20 0.36
NPY1R P25929 1/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
TPSAB1 Q15661 1/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2954469 1.00 CHRM1 (0.39) CHRM1NPY5RPDCD1CD274HTR7
SCHEMBL2953419 0.87 NPY5R (0.41) NPY5RHTR7HTR6ALOX5APFEN1
SCHEMBL2953421 0.87 NPY5R (0.41) NPY5RHTR7HTR6ALOX5APFEN1
SCHEMBL2949903 0.76 HSD11B1 (0.43) CHRM1HTR6ALOX5APFEN1POLB
SCHEMBL2949904 0.76 HSD11B1 (0.43) CHRM1HTR6ALOX5APFEN1POLB
SCHEMBL4727809 0.74 CHRM1 (0.51) CHRM1HTR7HTR6ALOX5APFEN1
SCHEMBL5244241 0.72 NPY2R (0.32)
SCHEMBL4726186 0.72 CHRM1 (0.47) CHRM1POLBALDH1A1
SCHEMBL4779943 0.71 EBP (0.50) CHRM1NPY5RHTR7HTR6HTR1A
SCHEMBL5086408 0.69 CHRM1 (0.50) CHRM1HTR7HTR6ALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060223829-A1 Hydroxysteroid dehydrogenase inhibitors TAKEDA SAN DIEGO, INC. 2006-10-05 US claimed
US-7759339-B2 Hydroxysteroid dehydrogenase inhibitors TAKEDA SAN DIEGO, INC. (US) 2010-07-20 US disclosed
EP-1866298-A2 HYDROXYSTEROID DEHYDROGENASE INHIBITORS Takeda San Diego, Inc. (US) 2007-12-19 EP disclosed
WO-2006105127-A2 HYDROXYSTEROID DEHYDROGENASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2006-10-05 WO disclosed
US-20060223829-A1 Hydroxysteroid dehydrogenase inhibitors TAKEDA SAN DIEGO, INC. 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223829-A1 Hydroxysteroid dehydrogenase inhibitors HSD17B1, HSD17B3, HSD17B2 CHRM1 4591/4885NPY5R 4026/4885PDCD1 4137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.